offline
About Avinger, Inc.
Avinger is a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.
Avinger Receives FDA Clearance of Pantheris SV Device
GlobeNewswire•April 10, 2019
Expands Addressable Market by Allowing for Treatment of Small Vessel Disease
REDWOOD CITY, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pantheris SV (Small Vessel) image-guided atherectomy system.....
https://finance.yahoo.com/news/avinger-r...Rt9rnCNI3a
Avinger is a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.
Avinger Receives FDA Clearance of Pantheris SV Device
GlobeNewswire•April 10, 2019
Expands Addressable Market by Allowing for Treatment of Small Vessel Disease
REDWOOD CITY, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pantheris SV (Small Vessel) image-guided atherectomy system.....
https://finance.yahoo.com/news/avinger-r...Rt9rnCNI3a
__________________
